A detailed history of Axxcess Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Axxcess Wealth Management, LLC holds 64,748 shares of ABBV stock, worth $11.7 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
64,748
Previous 67,497 4.07%
Holding current value
$11.7 Million
Previous $11.6 Million 10.44%
% of portfolio
0.33%
Previous 0.32%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$163.84 - $199.33 $450,396 - $547,958
-2,749 Reduced 4.07%
64,748 $12.8 Million
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $291,624 - $340,551
-1,884 Reduced 2.72%
67,497 $11.6 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $121,782 - $138,760
-762 Reduced 1.09%
69,381 $12.6 Million
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $786,659 - $885,963
5,717 Added 8.87%
70,143 $10.9 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $4.15 Million - $4.8 Million
31,054 Added 93.05%
64,426 $9.6 Million
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $1.47 Million - $1.82 Million
-11,067 Reduced 24.9%
33,372 $4.5 Million
Q1 2023

May 03, 2023

BUY
$144.61 - $166.54 $341,713 - $393,534
2,363 Added 5.62%
44,439 $7.08 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $1.34 Million - $1.6 Million
9,662 Added 29.81%
42,076 $6.8 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $353,643 - $405,605
-2,635 Reduced 7.52%
32,414 $4.35 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $736,404 - $936,210
-5,351 Reduced 13.25%
35,049 $5.37 Million
Q1 2022

Aug 11, 2022

BUY
$131.98 - $163.75 $697,250 - $865,091
5,283 Added 15.04%
40,400 $6.55 Million
Q4 2021

Aug 11, 2022

BUY
$107.43 - $135.93 $3.77 Million - $4.77 Million
35,117 New
35,117 $4.76 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Axxcess Wealth Management, LLC Portfolio

Follow Axxcess Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axxcess Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axxcess Wealth Management, LLC with notifications on news.